Skip links

Quick Updates

Wishing everybody a Happy Thanksgiving from QuarkBio!

We are thankful this year for the development contract signed this week with Amwise Diagnostics to develop RecurIndex® (the only Asian-specific breast cancer treatment selection panel on the market) using QuarkBio's PanelChip® Analysis System. Together, we will enter the Chinese market, starting with a clinical

Happy Halloween!

Happy #Halloween from Quark Biosciences! Remember, you're never too old to beg for free treats, so come ask us for your interesting #miRNA fact today! #miHalloweenTreat

Using Expression Biomarkers to Improve Pediatric Cancer Care

While not as prevalent as other cancer diseases, every day, 43 children are diagnosed with cancer. Children’s cancer affects all ethnic, gender and socio-economic groups and more than 40,000 children undergo treatment for cancer each year. 12% of children diagnosed with cancer do not survive,

A Novel Multi-Gene Detection Platform for the Analysis of miRNA Expression

QuarkBio’s newest publication demonstrates the use of QuarkBio’s PanelChip™ Analysis System as a powerful technology for discovering and validating extracellular miRNA cancer biomarkers. By analyzing miRNA levels in the plasma, we were able to discover miRNA expression patterns capable of separating healthy subjects from patients with oral

New Collaboration With Min-Sheng General Hospital

QuarkBio has partnered with Min-Sheng General Hospital, one of the top hospitals in Taiwan, to implement an early stage cancer detection tool for multiple types of cancer. Min-Sheng General Hospital will be providing 1,000 clinical samples as a trial run before providing the detection test as
Close Bitnami banner
Bitnami